Skip to main content
PMC home page
Annals of Surgery logoLink to Annals of Surgery
. 1987 Oct;206(4):529–541. doi: 10.1097/00000658-198710000-00014

Splenectomy for primary and recurrent immune thrombocytopenic purpura (ITP). Current criteria for patient selection and results.

O E Akwari 1, K M Itani 1, R E Coleman 1, W F Rosse 1
PMCID: PMC1493222  PMID: 3662662

Abstract

Of 565 patients with thrombocytopenia admitted to Duke University Hospital between 1975 and 1985, 100 had splenectomy. Ninety-eight patients had failed chronic immunosuppressive therapy and three patients had acute intracranial bleeding or total absence of platelets in the peripheral blood smear, and had urgent splenectomy. At primary splenectomy, accessory spleens were identified and resected in 18% of patients. There was no operative mortality. Fifty-eight patients had an excellent response to splenectomy and their steroids were tapered off within 3 weeks. Thirteen patients had a poor response to primary splenectomy of whom eight remitted spontaneously and five required accessory splenectomy resulting in complete remission in three patients. Twenty-nine patients were considered nonresponders, 25 of whom had radionuclide scanning for accessory spleens. Seven of these patients had accessory spleens identified but only four consented to accessory splenectomy. In three of the four patients, a complete remission was achieved. Neither platelet antibody titers nor measurements of platelet survival or turnover predicted platelet response to splenectomy. However, immune thrombocytopenic purpura (ITP) in older patients was significantly less likely to respond to splenectomy. These data support continuing use of splenectomy in selected patients with ITP and an aggressive search for accessory spleens in patients who relapse since they are easily localized at operation by hand-held isotope detector probe.

Full text

PDF
539

Images in this article

537Fig. 6.
on p.537

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ASTER R. H., JANDL J. H. PLATELET SEQUESTRATION IN MAN. II. IMMUNOLOGICAL AND CLINICAL STUDIES. J Clin Invest. 1964 May;43:856–869. doi: 10.1172/JCI104971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ambriz P., Muñz R., Quintanar E., Sigler L., Avilés A., Pizzuto J. Accessory spleen compromising response to splenectomy for idiopathic thrombocytopenic purpura. Radiology. 1985 Jun;155(3):793–796. doi: 10.1148/radiology.155.3.4039827. [DOI] [PubMed] [Google Scholar]
  3. Aspnes G. T., Pearson H. A., Spencer R. P., Pickett L. K. Recurrent idiopathic thrombocytopenia purpura with "accessory" splenic tissue. Pediatrics. 1975 Jan;55(1):131–134. [PubMed] [Google Scholar]
  4. Aster R. H. Platelet sequestration studies in man. Br J Haematol. 1972 Mar;22(3):259–263. doi: 10.1111/j.1365-2141.1972.tb05671.x. [DOI] [PubMed] [Google Scholar]
  5. Baldini M. G. Platelet production and destruction in idiopathic thrombocytopenic purpura: a controversial issue. JAMA. 1978 Jun 9;239(23):2477–2479. doi: 10.1001/jama.239.23.2477. [DOI] [PubMed] [Google Scholar]
  6. Branehög I., Kutti J., Weinfeld A. Platelet survival and platelet production in idiopathic thrombocytopenic purpura (ITP). Br J Haematol. 1974 May;27(1):127–143. doi: 10.1111/j.1365-2141.1974.tb06780.x. [DOI] [PubMed] [Google Scholar]
  7. Burger T., Schmelczer M., Kett K., Kutas J. Immune thrombocytolytic purpura (ITP): a diagnostic and therapeutic survey of 86 cases with regard to the results of splenectomy and conservative therapy. Acta Med Acad Sci Hung. 1978;35(3-4):213–224. [PubMed] [Google Scholar]
  8. CARPENTER A. F., WINTROBE M. M., FULLER E. A., HAUT A., CARTWRIGHT G. E. Treatment of idiopathic thrombocytopenic purpura. J Am Med Assoc. 1959 Dec 5;171:1911–1916. doi: 10.1001/jama.1959.03010320001001. [DOI] [PubMed] [Google Scholar]
  9. Carey R. W., McGinnis A., Jacobson B. M., Carvalho A. Idiopathic thrombocytopenic purpura complicating chronic lymphocytic leukemia. Arch Intern Med. 1976 Jan;136(1):62–66. [PubMed] [Google Scholar]
  10. Charlesworth D., Torrance H. B. Splenectomy in idiopath0cthrombocytopenic purpura. Br J Surg. 1968 Jun;55(6):437–439. doi: 10.1002/bjs.1800550608. [DOI] [PubMed] [Google Scholar]
  11. Coon W. W. Splenectomy for idiopathic thrombocytopenic purpura. Surg Gynecol Obstet. 1987 Mar;164(3):225–229. [PubMed] [Google Scholar]
  12. DAMESHEK W. Systemic lupus erythematosus: a complex auto-immune disorder. Ann Intern Med. 1958 Apr;48(4):707–730. doi: 10.7326/0003-4819-48-4-707. [DOI] [PubMed] [Google Scholar]
  13. DEWEESE M. S., COLLER F. A. Splenectomy for hematologic disorders. West J Surg Obstet Gynecol. 1959 May-Jun;67(3):129–138. [PubMed] [Google Scholar]
  14. Davis H. H., 2nd, Varki A., Heaton W. A., Siegel B. A. Detection of accessory spleens with indium 111-labeled autologous platelets. Am J Hematol. 1980;8(1):81–86. doi: 10.1002/ajh.2830080110. [DOI] [PubMed] [Google Scholar]
  15. Dewanjee M. K., Wahner H. W., Dunn W. L., Robertson J. S., Offord K. P., Fuster V. D., Chesebro J. H. Comparison of three platelet markers for measurement of platelet survival time in healthy volunteers. Mayo Clin Proc. 1986 May;61(5):327–336. doi: 10.1016/s0025-6196(12)61949-1. [DOI] [PubMed] [Google Scholar]
  16. DiFino S. M., Lachant N. A., Kirshner J. J., Gottlieb A. J. Adult idiopathic thrombocytopenic purpura. Clinical findings and response to therapy. Am J Med. 1980 Sep;69(3):430–442. doi: 10.1016/0002-9343(80)90016-9. [DOI] [PubMed] [Google Scholar]
  17. Dixon R. H., Rosse W. F. Platelet antibody in autoimmune thrombocytopenia. Br J Haematol. 1975 Oct;31(2):129–134. doi: 10.1111/j.1365-2141.1975.tb00843.x. [DOI] [PubMed] [Google Scholar]
  18. ELLIOTT R. H. E., Jr, TURNER J. C. Splenectomy for purpura hemorrhagica. Surg Gynecol Obstet. 1951 May;92(5):539–544. [PubMed] [Google Scholar]
  19. EVANS R. S., TAKAHASHI K., DUANE R. T., PAYNE R., LIU C. Primary thrombocytopenic purpura and acquired hemolytic anemia; evidence for a common etiology. AMA Arch Intern Med. 1951 Jan;87(1):48–65. doi: 10.1001/archinte.1951.03810010058005. [DOI] [PubMed] [Google Scholar]
  20. EVANS T. S., SPINNER S., PICCOLO P., SWIRKSY M., WHITE R., KIESEWETTER W. Recurrent hypersplenism due to accessory spleen. Acta Haematol. 1953 Dec;10(6):350–359. doi: 10.1159/000204445. [DOI] [PubMed] [Google Scholar]
  21. Eliason E. L., Ferguson L. K. Splenectomy in Purpura Hemorrhagica. Ann Surg. 1932 Nov;96(5):801–829. doi: 10.1097/00000658-193211000-00001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Finch S. C., Castro O., Cooper M., Covey W., Erichson R., McPhedran P. Immunosuppressive therapy of chronic idiopathic thrombocytopenic purpura. Am J Med. 1974 Jan;56(1):4–12. doi: 10.1016/0002-9343(74)90745-1. [DOI] [PubMed] [Google Scholar]
  23. Fink K., Al-Mondhiry H. Idiopathic thrombocytopenic purpura in lymphoma. Cancer. 1976 Apr;37(4):1999–2004. doi: 10.1002/1097-0142(197604)37:4<1999::aid-cncr2820370451>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  24. HARRINGTON W. J., MINNICH V., HOLLINGSWORTH J. W., MOORE C. V. Demonstration of a thrombocytopenic factor in the blood of patients with thrombocytopenic purpura. J Lab Clin Med. 1951 Jul;38(1):1–10. [PubMed] [Google Scholar]
  25. HARRINGTON W. J., SPRAGUE C. C., MINNICH V., MOORE C. V., AULVIN R. C., DUBACH R. Immunologic mechanisms in idiopathic and neonatal thrombocytopenic purpura. Ann Intern Med. 1953 Mar;38(3):433–469. doi: 10.7326/0003-4819-38-3-433. [DOI] [PubMed] [Google Scholar]
  26. Hann I. M., Wainscoat J. S. Recurrent thrombocytopenic purpura associated with accessory spleen. Arch Dis Child. 1976 Feb;51(2):154–156. doi: 10.1136/adc.51.2.154. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Harker L. A. Thrombokinetics in idiopathic thrombocytopenic purpura. Br J Haematol. 1970 Jul;19(1):95–104. doi: 10.1111/j.1365-2141.1970.tb01605.x. [DOI] [PubMed] [Google Scholar]
  28. Heyns A. D., Lötter M. G., Badenhorst P. N., de Kock F., Pieters H., Herbst C., van Reenen O. R., Kotze H., Minnaar P. C. Kinetics and sites of destruction of 111Indium-oxine-labeled platelets in idiopathic thrombocytopenic purpura: a quantitative study. Am J Hematol. 1982 Apr;12(2):167–177. doi: 10.1002/ajh.2830120209. [DOI] [PubMed] [Google Scholar]
  29. JiJi R. M., Firozvi T., Spurling C. L. Chronic idiopathic thrombocytopenic purpura. Treatment with steroids and splenectomy. Arch Intern Med. 1973 Sep;132(3):380–383. [PubMed] [Google Scholar]
  30. Kayser W., Mueller-Eckhardt C., Mueller-Eckhardt G. The value of platelet-associated IgG in predicting the efficacy of splenectomy in autoimmune thrombocytopenia. Scand J Haematol. 1983 Jan;30(1):30–35. doi: 10.1111/j.1600-0609.1983.tb00631.x. [DOI] [PubMed] [Google Scholar]
  31. Kelton J. G., Carter C. J., Rodger C., Bebenek G., Gauldie J., Sheridan D., Kassam Y. B., Kean W. F., Buchanan W. W., Rooney P. J. The relationship among platelet-associated IgG, platelet lifespan, and reticuloendothelial cell function. Blood. 1984 Jun;63(6):1434–1438. [PubMed] [Google Scholar]
  32. Kernoff M., Malan E. Platelet antibody levels do not correlate with response to therapy in idiopathic thrombocytopenic purpura. Br J Haematol. 1983 Apr;53(4):559–562. doi: 10.1111/j.1365-2141.1983.tb07307.x. [DOI] [PubMed] [Google Scholar]
  33. Lehman H. A., Lehman L. O., Rustagi P. K., Rustgi R. N., Plunkett R. W., Farolino D. L., Conway J., Logue G. L. Complement-mediated autoimmune thrombocytopenia. Monoclonal IgM antiplatelet antibody associated with lymphoreticular malignant disease. N Engl J Med. 1987 Jan 22;316(4):194–198. doi: 10.1056/NEJM198701223160406. [DOI] [PubMed] [Google Scholar]
  34. MEYERS M. C. Results of treatment in 71 patients with idiopathic thrombocytopenic purpura. Am J Med Sci. 1961 Sep;242:295–302. doi: 10.1097/00000441-196109000-00004. [DOI] [PubMed] [Google Scholar]
  35. Macpherson A. I., Richmond J. Planned splenectomy in treatment of idiopathic thrombocytopenic purpura. Br Med J. 1975 Jan 11;1(5949):64–66. doi: 10.1136/bmj.1.5949.64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Madura J. A., Johnson P., Rohn R. J. Recurrent thrombocytopenia caused by accessory spleen: a case report. J Indiana State Med Assoc. 1982 Jan;75(1):46–49. [PubMed] [Google Scholar]
  37. Mazur E. M., Field W. W., Cahow C. E., Schiffman F. J., Duffy T. P., Forget B. G. Idiopathic thrombocytopenic purpura occurring in a subject previously splenectomized for traumatic splenic rupture. Role of splenosis in the pathogenesis of thrombocytopenia. Am J Med. 1978 Nov;65(5):843–846. doi: 10.1016/0002-9343(78)90804-5. [DOI] [PubMed] [Google Scholar]
  38. McMillan R. Immune thrombocytopenia. Clin Haematol. 1983 Feb;12(1):69–88. [PubMed] [Google Scholar]
  39. McMillan R., Luiken G. A., Levy R., Yelenosky R., Longmire R. L. Antibody against megakaryocytes in idiopathic thrombocytopenic purpura. JAMA. 1978 Jun 9;239(23):2460–2462. doi: 10.1001/jama.239.23.2460. [DOI] [PubMed] [Google Scholar]
  40. Mintz S. J., Petersen S. R., Cheson B., Cordell L. J., Richards R. C. Splenectomy for immune thrombocytopenic purpura. Arch Surg. 1981 May;116(5):645–650. doi: 10.1001/archsurg.1981.01380170121022. [DOI] [PubMed] [Google Scholar]
  41. Morris L., Distenfeld A., Amorosi E., Karpatkin S. Autoimmune thrombocytopenic purpura in homosexual men. Ann Intern Med. 1982 Jun;96(6 Pt 1):714–717. doi: 10.7326/0003-4819-96-6-714. [DOI] [PubMed] [Google Scholar]
  42. Mueller-Eckhardt C., Kayser W., Mersch-Baumert K., Mueller-Eckhardt G., Breidenbach M., Kugel H. G., Graubner M. The clinical significance of platelet-associated IgG: a study on 298 patients with various disorders. Br J Haematol. 1980 Sep;46(1):123–131. doi: 10.1111/j.1365-2141.1980.tb05942.x. [DOI] [PubMed] [Google Scholar]
  43. Murphy E. A., Francis M. E. The estimation of blood platelet survival. II. The multiple hit model. Thromb Diath Haemorrh. 1971;25(1):53–80. [PubMed] [Google Scholar]
  44. O'Reilly R. A., Taber B. Z. Immunologic thrombocytopenic purpura and pregnancy: six new cases. Obstet Gynecol. 1978 May;51(5):590–597. doi: 10.1097/00006250-197805000-00018. [DOI] [PubMed] [Google Scholar]
  45. Pawelski S., Konopka L., Zdziechowska H. Recurrence of thrombocytopenia in patients splenectomized for idiopathic thrombocytopenic purpura. Blut. 1981 Dec;43(6):355–360. doi: 10.1007/BF00320313. [DOI] [PubMed] [Google Scholar]
  46. Peters A. M., Lavender J. P. Platelet kinetics with indium-111 platelets: comparison with chromium-51 platelets. Semin Thromb Hemost. 1983 Apr;9(2):100–114. doi: 10.1055/s-2007-1005016. [DOI] [PubMed] [Google Scholar]
  47. ROBSON H. N., DUTHIE J. J. R. Capillary resistance and adrenocortical activity. Br Med J. 1950 Oct 28;2(4686):971–977. doi: 10.1136/bmj.2.4686.971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. ROSENTHAL N., VOGEL P., LEE S., LIPSAY J. The role of accessory spleens in post-splenectomy recurrent purpura hemorrhagica. J Mt Sinai Hosp N Y. 1951 Mar-Apr;17(6):1008–1020. [PubMed] [Google Scholar]
  49. Robertson J. S., Dewanjee M. K., Brown M. L., Fuster V., Cesebro J. H. Distribution and dosimetry of 111In-labeled platelets. Radiology. 1981 Jul;140(1):169–176. doi: 10.1148/radiology.140.1.7244222. [DOI] [PubMed] [Google Scholar]
  50. Rocco M. V., Stein R. S. Prognostic factors for splenectomy response in adult idiopathic thrombocytopenic purpura. South Med J. 1984 Aug;77(8):983–987. doi: 10.1097/00007611-198408000-00012. [DOI] [PubMed] [Google Scholar]
  51. Rolovic Z., Baldini M., Dameshek W. Megakaryocytopoiesis in experimentally induced immune thrombocytopenia. Blood. 1970 Feb;35(2):173–188. [PubMed] [Google Scholar]
  52. Rosse W. F. Treatment of chronic immune thrombocytopenia. Clin Haematol. 1983 Feb;12(1):267–284. [PubMed] [Google Scholar]
  53. Rudowski W. J. Accessory spleens: clinical significance with particular reference to the recurrence of idiopathic thrombocytopenic purpura. World J Surg. 1985 Jun;9(3):422–430. doi: 10.1007/BF01655277. [DOI] [PubMed] [Google Scholar]
  54. Scheffel U., Tsan M. F., Mitchell T. G., Camargo E. E., Braine H., Ezekowitz M. D., Nickoloff E. L., Hill-Zobel R., Murphy E., McIntyre P. A. Human platelets labeled with In-111 8-hydroxyquinoline: kinetics, distribution, and estimates of radiation dose. J Nucl Med. 1982 Feb;23(2):149–156. [PubMed] [Google Scholar]
  55. Schreiber A. D., Chien P., Tomaski A., Cines D. B. Effect of danazol in immune thrombocytopenic purpura. N Engl J Med. 1987 Feb 26;316(9):503–508. doi: 10.1056/NEJM198702263160903. [DOI] [PubMed] [Google Scholar]
  56. Schwartz S. I., Hoepp L. M., Sachs S. Splenectomy for thrombocytopenia. Surgery. 1980 Oct;88(4):497–506. [PubMed] [Google Scholar]
  57. Spero J. A., Lewis J. H., Hasiba U., Gumerman L. W. Splenunculectomy in recurrent thrombocytopenia. Acta Haematol. 1976;55(6):354–357. doi: 10.1159/000208040. [DOI] [PubMed] [Google Scholar]
  58. Sweeney J. D., Keane F. B., Freyne P. J., Temperley I. J., McCann S. R. Accessory splenic tissue in a patient with relapsed idiopathic thrombocytopenic purpura. Clin Lab Haematol. 1982;4(3):309–312. doi: 10.1111/j.1365-2257.1982.tb00080.x. [DOI] [PubMed] [Google Scholar]
  59. Thakur M. L., Welch M. J., Joist J. H., Coleman R. E. Indium-LLL labeled platelets: studies on preparation and evaluation of in vitro and in vivo functions. Thromb Res. 1976 Oct;9(4):345–357. doi: 10.1016/0049-3848(76)90135-3. [DOI] [PubMed] [Google Scholar]
  60. Thorek P., Gradman R., Welch J. S. Recurrent Primary Thrombocytopenic Purpura with Accessory Spleens: Review of the Literature. Ann Surg. 1948 Aug;128(2):304–311. doi: 10.1097/00000658-194808000-00013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Verheyden C. N., Beart R. W., Jr, Clifton M. D., Phyliky R. L. Accessory splenectomy in management of recurrent idiopathic thrombocytopenic purpura. Mayo Clin Proc. 1978 Jul;53(7):442–446. [PubMed] [Google Scholar]
  62. Voet D., Afschrift M., Nachtegaele P., Delbeke M. J., Schelstraete K., Benoit Y. Sonographic diagnosis of an accessory spleen in recurrent idiopathic thrombocytopenic purpura. Pediatr Radiol. 1983;13(1):39–41. doi: 10.1007/BF00975665. [DOI] [PubMed] [Google Scholar]
  63. Wallace D., Fromm D., Thomas D. Accessory splenectomy for idiopathic thrombocytopenic purpura. Surgery. 1982 Feb;91(2):134–136. [PubMed] [Google Scholar]
  64. Wang G., Ahn Y. S., Whitcomb C. C., Harrington W. J. Development of polycythemia vera and chronic lymphocytic leukemia during the course of refractory idiopathic thrombocytopenic purpura. Cancer. 1984 Apr 15;53(8):1770–1776. doi: 10.1002/1097-0142(19840415)53:8<1770::aid-cncr2820530827>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  65. Wilde R. C., Ellis L. D., Cooper W. M. Splenectomy for chronic idiopathic thrombocytopenic purpura. Arch Surg. 1967 Sep;95(3):344–350. doi: 10.1001/archsurg.1967.01330150020004. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES